4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-19-041757
Director sold 6,000 shares at an average $42.60 ($255,570)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kurkijarvi Kalevi · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-08 | Exercise or conversion : show line 1 in the form | +6,000 | $3.50 | $21,000 | 34,400 | D |
| 2019-07-08 | Sale : show line 2 in the form | −4,600 | $42.35 | $194,810 | 29,800 | D |
| 2019-07-08 | Sale : show line 3 in the form | −1,400 | $43.40 | $60,760 | 28,400 | D |
| Open-market sales · 6,000 sh · avg $42.60 · $255,570 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-07-08 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,000 | $3.50 | 2021-03-15 | 6,000 | 6,000 | D |
Loading xslF345X03/doc4.xml…